Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Convergent evolution on <i>RBA1</i> regulates <i>Candidozyma auris</i> host adaptation
Laura A Doorley, Alyssa A La Bella, Sarah J Jones, et al.
Biorxiv : the Preprint Server for Biology
|
July 9, 2025
Nutrient excess remodels islet autonomic innervation via pancreatic schwann cells
R F Hampton, M Jimenez-Gonzalez, R Kang, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic <i>ROS1</i>-Rearranged Lung Cancers
Noura J Choudhury, Jaime L Schneider, Tejas Patil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 11, 2022
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas
P Selenica, A Marra, N J Choudhury, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 23, 2024
First-in-human imaging with [<sup>89</sup>Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate
Salomon Tendler, Mark P Dunphy, Matthew Agee, et al.
The Lancet. Oncology
|
July 1, 2024
Imaging with [<sup>89</sup>Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
Salomon Tendler, Mark P Dunphy, Matthew Agee, et al.
Cancer
|
January 29, 2025
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer
Jacob M Sands, Stéphane Champiat, Horst-Dieter Hummel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 9, 2022
Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers
Noura J Choudhury, Antonio Marra, Jane S Y Sui, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 19, 2025
Clinical Significance of MTAP Deletions and their Overlap with Concurrent Oncogenic Driver Alterations Including EGFR in Non-Small Cell Lung Cancer
Jessica S Ross, Rohit Thummalapalli, Christopher A Febres-Aldana, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2026
Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation
R Philips, A Mahajan, L Estephan, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Convergent evolution on <i>RBA1</i> regulates <i>Candidozyma auris</i> host adaptation
Laura A Doorley, Alyssa A La Bella, Sarah J Jones, et al.
Biorxiv : the Preprint Server for Biology
|
July 9, 2025
Nutrient excess remodels islet autonomic innervation via pancreatic schwann cells
R F Hampton, M Jimenez-Gonzalez, R Kang, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic <i>ROS1</i>-Rearranged Lung Cancers
Noura J Choudhury, Jaime L Schneider, Tejas Patil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 11, 2022
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas
P Selenica, A Marra, N J Choudhury, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 23, 2024
First-in-human imaging with [<sup>89</sup>Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate
Salomon Tendler, Mark P Dunphy, Matthew Agee, et al.
The Lancet. Oncology
|
July 1, 2024
Imaging with [<sup>89</sup>Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
Salomon Tendler, Mark P Dunphy, Matthew Agee, et al.
Cancer
|
January 29, 2025
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer
Jacob M Sands, Stéphane Champiat, Horst-Dieter Hummel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 9, 2022
Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers
Noura J Choudhury, Antonio Marra, Jane S Y Sui, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 19, 2025
Clinical Significance of MTAP Deletions and their Overlap with Concurrent Oncogenic Driver Alterations Including EGFR in Non-Small Cell Lung Cancer
Jessica S Ross, Rohit Thummalapalli, Christopher A Febres-Aldana, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2026
Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation
R Philips, A Mahajan, L Estephan, et al.
Page
of 6